//img.uscri.be/pth/215c7ad86d467aa4c7b76ae23d9ae044a8c6f576
Cet ouvrage fait partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour le lire en ligne
En savoir plus

Increasing Incidence of Osteoarthritis and Osteoporosis Driving Collagen Peptide Market, Finds Frost & Sullivan

2 pages
Increasing Incidence of Osteoarthritis and Osteoporosis Driving Collagen Peptide Market, Finds Frost & Sullivan PR Newswire MOUNTAIN VIEW, California, June 26, 2012 - Market propelled further by manufacturers investing on research and development to prove product efficacy MOUNTAIN VIEW, California, June 26, 2012 /PRNewswire/ -- One of the main challenges faced by the collagen peptide industry is fierce competition from established ingredients like chondroitin sulfate and glucosamine. Manufacturers, however, are combating this situation by conducting numerous studies in order to prove the efficacy of collagen peptides and show the benefits of combining peptides with other ingredients. New analysis from Frost & Sullivan (http://www.food.frost.com), Strategic Analysis of the Collagen Peptide Market in the United States, finds that the market earned revenues of $224.6 million in 2011. It is expected to increase to $344.5 million by 2017. If you are interested in more information on this research, please send an email to Jeannette Garcia, Corporate Communications, at jeannette.garcia@frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. The increasing incidence of osteoporosis and osteoarthritis, combined with an aging population globally, promises a great growth potential for collagen peptides.
Voir plus Voir moins
Increasing Incidence of Osteoarthritis and
Osteoporosis Driving Collagen Peptide Market,
Finds Frost & Sullivan
PR Newswire
MOUNTAIN VIEW, California, June 26, 2012
- Market propelled further by manufacturers investing on research
and development to prove product efficacy
MOUNTAIN VIEW, California
,
June 26, 2012
/PRNewswire/ -- One of the main
challenges faced by the collagen peptide industry is fierce competition from
established ingredients like chondroitin sulfate and glucosamine.
Manufacturers, however, are combating this situation by conducting numerous
studies in order to prove the efficacy of collagen peptides and show the
benefits of combining peptides with other ingredients.
New analysis from Frost & Sullivan (http://www.food.frost.com),
Strategic
Analysis of the Collagen Peptide Market in
the United States
, finds that
the market earned revenues of
$224.6 million
in 2011. It is expected to
increase to
$344.5 million
by 2017.
If you are interested in more information on this research, please send an
email to Jeannette Garcia, Corporate Communications, at
jeannette.garcia@frost.com, with your full name, company name, title,
telephone number, company email address, company website, city, state and
country.
The increasing incidence of osteoporosis and osteoarthritis, combined with an
aging population globally, promises a great growth potential for collagen
peptides.
"Collagen peptides have the ability to cure bone- and joint-related ailments
without causing any side effects," said Research Associate Ashwin Raj Ravinder.
"Moreover, the protein is known for its use in cosmetic applications to retain a
youthful appearance. Both characteristics will help manufacturers garner a
greater penetration."
The constantly increasing demand to stay young is accomplished by consuming
collagen peptides within functional foods and beverages, as well as in dietary
supplements. The concept of blending collagen peptides with first generation
ingredients, such as chondroitin, has caused a boom in the market.
None the less, there is a lower awareness amongst consumers to want collagen
peptide enriched products because there is a lack of health claims that support
the benefits of the ingredient. Manufacturers should invest on more research
and development, marketing and conducting human clinical studies to prove
the efficacy of collagen peptides.
"Manufacturers must look at blending collagen peptides with other well-known,
complementary ingredients in the market like chondroitin and glucosamine in
order to gain a significant market share," said Ravinder. "Increasing marketing
activities and creating awareness amongst consumers is always essential."
Strategic Analysis of the Collagen Peptide Market in
the United
States
is part of the
Food & Beverage
Growth Partnership Services program,
which also includes research in the following markets: US Bone & Joint Health